1. Home
  2. TDW vs CRNX Comparison

TDW vs CRNX Comparison

Compare TDW & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tidewater Inc.

TDW

Tidewater Inc.

HOLD

Current Price

$78.25

Market Cap

4.3B

ML Signal

HOLD

Logo Crinetics Pharmaceuticals Inc.

CRNX

Crinetics Pharmaceuticals Inc.

HOLD

Current Price

$83.74

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TDW
CRNX
Founded
1956
2008
Country
United States
United States
Employees
7300
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
3.9B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
TDW
CRNX
Price
$78.25
$83.74
Analyst Decision
Hold
Strong Buy
Analyst Count
4
8
Target Price
$81.33
$76.75
AVG Volume (30 Days)
651.6K
6.8M
Earning Date
05-04-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,039,000.00
Revenue This Year
$8.44
$720.10
Revenue Next Year
$12.34
$184.67
P/E Ratio
$24.08
N/A
Revenue Growth
N/A
N/A
52 Week Low
$46.65
$25.83
52 Week High
$93.13
$84.00

Technical Indicators

Market Signals
Indicator
TDW
CRNX
Relative Strength Index (RSI) 62.88 92.07
Support Level $76.82 $33.50
Resistance Level $88.24 N/A
Average True Range (ATR) 2.75 0.18
MACD 0.89 -0.10
Stochastic Oscillator 88.16 53.51

Price Performance

Historical Comparison
TDW
CRNX

About TDW Tidewater Inc.

Tidewater Inc provides marine and transportation services to the offshore energy industry. The company's vessels and associated services support all phases of offshore crude oil and natural gas (also referred to as oil and gas) exploration activities, field development, production, and maintenance, as well as windfarm development and maintenance. Its services include towing and anchor handling for mobile offshore drilling units; transporting supplies and personnel necessary to sustain drilling, workovers, production activities, field abandonment, dismantlement, and restoration activities; and Others. The group manages its business through five segments, including the Americas, Asia Pacific, Middle East, Europe/Mediterranean, and West Africa.

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltusotine), is a once-daily, oral treatment approved by the FDA for adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. Additionally, the company's development pipeline includes several programs, including a late-stage investigational candidate, atumelnant, currently in development for CAH and ADCS, and CRN09682, a NDC candidate that is being developed to treat SST2-expressing NETs and other SST2-expressing solid tumors.

Share on Social Networks: